Inventor · disambiguated record
Rajiv Sharma
Also filed as: SHARMA RAJIV
38 granted patents·18 pending applications·440 citations·filing 1995–2023
97Inventor score
Files withAMGEN INC13PIRAMAL ENTPR LTD10BOEHRINGER INGELHEIM PHARMA6CADILA HEALTHCARE LTD5KUMAR SANJAY3
Top patents by PatentIndex Score
56 records- 0194US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 0294US6869975B2Linked biaryl compoundsTULARIK INC·Filed 2002·Granted Mar 22, 2005·78 cites·28 claims
- 0394US6492393B1Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Dec 10, 2002·70 cites·12 claims
- 0491US6506747B1Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Jan 14, 2003·136 cites·15 claims
- 0589US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 0687US6660732B2Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 9, 2003·24 cites·22 claims
- 0785US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 0884US9062046B2Substituted imidazoquinoline derivatives as kinase inhibitorsKUMAR SANJAY·Filed 2011·Granted Jun 23, 2015·12 cites·14 claims
- 0983US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 1081US6353007B1Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Mar 5, 2002·17 cites·15 claims
- 1180US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 1278US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 1378US7358250B2Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activityAMGEN INC·Filed 2005·Granted Apr 15, 2008·4 cites·22 claims
- 1477US7645779B2Linked biaryl compoundsAMGEN INC·Filed 2004·Granted Jan 12, 2010·9 cites·24 claims
- 1575US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 1674US11236045B2Substituted sulfoximine compoundsCADILA HEALTHCARE LTD·Filed 2018·Granted Feb 1, 2022·1 cites·7 claims
- 1774US7019006B2Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 28, 2006·5 cites·17 claims
- 1874US6451820B1Substituted 1-(4-aminophenly)triazoles and their use as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Sep 17, 2002·6 cites·12 claims
- 1973US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 2071US8748426B2Inhibitors of diacylglycerol acyl transferaseJADHAV RAVINDRA DNYANDEV·Filed 2010·Granted Jun 10, 2014·5 cites·30 claims
- 2171US2024122989A1Methods and compositions for production of genetically modified primary cellsGRAPHITE BIO INC·Filed 2023·Application pending·0 cites
- 2270US10899713B2Process for the preparation of quinolone based compoundsCADILA HEALTHCARE LTD·Filed 2019·Granted Jan 26, 2021·1 cites·55 claims
- 2367US11339153B2Compounds useful in modulating the farnesoid X receptor and methods of making and using the sameINORBIT THERAPEUTICS AB·Filed 2019·Granted May 24, 2022·1 cites·17 claims
- 2465US2023089784A1Methods and compositions for production of genetically modified primary cellsGRAPHITE BIO INC·Filed 2022·Application pending·0 cites
- 2564US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 2663US5874464AConformationally constrained diacylglycerol analoguesUS HEALTH·Filed 1995·Granted Feb 23, 1999·12 cites·12 claims
- 2758US10227360B2Compounds for use as GPR120 agonistsPIRAMAL ENTPR LTD·Filed 2015·Granted Mar 12, 2019·1 cites·28 claims
- 2856US11773077B2Compounds containing carbon-carbon linker as GPR120 agonistsPIRAMAL ENTPR LTD·Filed 2020·Granted Oct 3, 2023·0 cites·23 claims
- 2956US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 3055US12377070B2Substituted sulfoximine derivativesCADILA HEALTHCARE LTD·Filed 2020·Granted Aug 5, 2025·0 cites·7 claims
- 3155US2014045832A1Insulin-Like Growth Factor-1 Receptor InhibitorsBALACHANDRAN SARALA·Filed 2012·Application pending·0 cites
- 3254US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 3353US2024300899A1A quinolone compound in solid forms and processes for the preparation thereofZYDUS LIFESCIENCES LTD·Filed 2022·Application pending·0 cites
- 3452US2022145286A1Barcoded clonal tracking of gene targeting in cellsCHAN ZUCKERBERG BIOHUB INC·Filed 2020·Application pending·0 cites
- 3550US2024327407A1Novel inhibitors of autotaxinCADILA HEAL THCARE LTD·Filed 2021·Application pending·0 cites
- 3649US10941133B2Compounds containing carbon-carbon linker as GPR120 agonistsPIRAMAL ENTPR LTD·Filed 2016·Granted Mar 9, 2021·0 cites·13 claims
- 3747US12084416B2Substituted sulfonylurea derivativesZYDUS LIFESCIENCES LTD·Filed 2020·Granted Sep 10, 2024·0 cites·13 claims
- 3847US2023089247A1Novel compounds suitable for the treatment of dyslipidemiaZYDUS LIFESCIENCES LTD·Filed 2020·Application pending·0 cites
- 3946US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 4045US9475842B2Hexadepsipeptide analogues as anticancer compoundsPIRAMAL ENTPR LTD·Filed 2013·Granted Oct 25, 2016·0 cites·16 claims
- 4144US2023096663A1Farnesoid x receptor modulating compounds and methods of using the sameINORBIT THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 4243US2010137323A1Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2010·Application pending·0 cites
- 4340US2021052597A1Heterocyclic compounds useful as antibacterial agentsCADILA HEALTHCARE LTD·Filed 2019·Application pending·0 cites
- 4439US2022169603A1Novel salts, crystalline forms and premix of hypolipidemic agentCADILA HEALTHCARE LTD·Filed 2020·Application pending·0 cites
- 4539US2015119394A1Insulin-Like Growth Factor-1 Receptor InhibitorsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 4637US2015072969A1Phenyl alkanoic acid derivatives as gpr agonistsPIRAMAL ENTPR LTD·Filed 2013·Application pending·0 cites
- 4735US2016354430A1Hexadepsipeptide analogues as anticancer compoundsPIRAMAL ENTPR LTD·Filed 2016·Application pending·0 cites
- 4832US10214521B2Fused heterocyclic compounds as GPR120 agonistsPIRAMAL ENTPR LTD·Filed 2015·Granted Feb 26, 2019·0 cites·12 claims
- 4932US2013310374A1Substituted Imidazoquinoline DerivativesKUMAR SANJAY·Filed 2011·Application pending·0 cites
- 5029US10273230B2Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereofPIRAMAL ENTPR LTD·Filed 2015·Granted Apr 30, 2019·0 cites·18 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rajiv Sharma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →